GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NUTEX Investments PLC (BUD:NUTEX) » Definitions » EV-to-Revenue

NUTEX Investments (BUD:NUTEX) EV-to-Revenue : -4,467.86 (As of Apr. 27, 2024)


View and export this data going back to 1996. Start your Free Trial

What is NUTEX Investments EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, NUTEX Investments's enterprise value is Ft-2,010.54 Mil. NUTEX Investments's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was Ft0.45 Mil. Therefore, NUTEX Investments's EV-to-Revenue for today is -4,467.86.

The historical rank and industry rank for NUTEX Investments's EV-to-Revenue or its related term are showing as below:

BUD:NUTEX' s EV-to-Revenue Range Over the Past 10 Years
Min: -7462.13   Med: 0.69   Max: 856.77
Current: -4467.87

During the past 13 years, the highest EV-to-Revenue of NUTEX Investments was 856.77. The lowest was -7462.13. And the median was 0.69.

BUD:NUTEX's EV-to-Revenue is ranked better than
99.9% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs BUD:NUTEX: -4467.87

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-27), NUTEX Investments's stock price is Ft14.35. NUTEX Investments's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was Ft0.00. Therefore, NUTEX Investments's PS Ratio for today is 4,783.33.


NUTEX Investments EV-to-Revenue Historical Data

The historical data trend for NUTEX Investments's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NUTEX Investments EV-to-Revenue Chart

NUTEX Investments Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,482.58 -1,264.92 -4,756.03 -4,857.98 -4,517.22

NUTEX Investments Semi-Annual Data
Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,756.03 - -4,857.98 - -4,517.22

Competitive Comparison of NUTEX Investments's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, NUTEX Investments's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NUTEX Investments's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NUTEX Investments's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where NUTEX Investments's EV-to-Revenue falls into.



NUTEX Investments EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

NUTEX Investments's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-2010.537/0.45
=-4,467.86

NUTEX Investments's current Enterprise Value is Ft-2,010.54 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NUTEX Investments's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was Ft0.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NUTEX Investments  (BUD:NUTEX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

NUTEX Investments's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=14.35/0.003
=4,783.33

NUTEX Investments's share price for today is Ft14.35.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was Ft0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NUTEX Investments EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of NUTEX Investments's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


NUTEX Investments (BUD:NUTEX) Business Description

Traded in Other Exchanges
N/A
Address
Telepes u. 53., Budapest, HUN, 1147
NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.

NUTEX Investments (BUD:NUTEX) Headlines

No Headlines